FDA grants quick review for 3 psychedelic drug trials
FDA Commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this summer.
Opening excerpt (first ~120 words) tap to expand
FIRST ON NBC NEWSHealth newsHealth newsFDA grants quick review for 3 psychedelic drug trialsFDA Commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this summer.Listen to this article with a free account00:0000:00 body:has(.jw-flag-floating) .article-hero__container, body:has(.jw-flag-floating) .article-hero__media-holder, body:has(.jw-flag-floating) #content { z-index: auto; } Add NBC News to GoogleFDA moves to fast-track three psychedelic drugs for review02:00Get more newsLiveonShareAdd NBC News to GoogleApril 24, 2026, 9:00 AM EDT / Updated April 24, 2026, 4:44 PM EDTBy Erika EdwardsThe Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at NBC News.
Discussion
0 commentsMore from NBC News
